Stocks and Investing Stocks and Investing
Thu, April 21, 2022

Shagun Singh Maintained (ABT) at Buy with Decreased Target to $143 on, Apr 21st, 2022


Published on 2024-10-27 20:33:20 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $146 to $143 on, Apr 21st, 2022.

Shagun has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 0 agree with Shagun's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Shagun


  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
  • Travis Steed of "B of A Securities" Initiated at Strong Buy and Held Target at $140 on, Wednesday, March 2nd, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022
Contributing Sources